Profound Medical Corp.
NASDAQ: PROF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Arun Swarup Menawat
- Employees
- 142
- Headquarters
- Mississauga, Canada
- IPO year
- 2019
- Market cap
- $197.0M
- Website
- https://www.profoundmedical.com
Loading PROF…
Loading profile data…Frequently asked questions about PROF
What does Profound Medical Corp. (PROF) do?
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company...
Where does PROF trade?
Profound Medical Corp. (PROF) trades on the NASDAQ Capital Market.
What sector is PROF in?
Profound Medical Corp. (PROF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Profound Medical Corp.?
Arun Swarup Menawat is the chief executive officer of Profound Medical Corp. (PROF).
Where is Profound Medical Corp. headquartered?
Profound Medical Corp. is headquartered in Canada.
Does PROF pay a dividend?
Profound Medical Corp. (PROF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PROF go public?
Profound Medical Corp. (PROF) completed its initial public offering in 2019.